KFF November 28, 2023
With federal regulators seeking public input on the potential benefits, costs, and implementation considerations of requiring private health insurance plans to cover over-the-counter preventive products without a prescription, a new KFF post explores the issues relevant to covering over-the-counter contraceptives. These contraceptives include Opill, the first daily oral contraceptive pill to receive FDA approval for over-the-counter availability.
The analysis draws on the lessons learned from KFF staff interviews with more than 80 key players nationally and in states that have passed laws or taken other actions to expand access to birth control without...
Today's Sponsors
Today's Sponsor